Comparison between Medicamen Organics IPO and Akiko Global IPO.
Medicamen Organics IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Akiko Global IPO is a SME Bookbuilding proposed to list at NSE SME.
| Medicamen Organics IPO | Akiko Global IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | GYR Capital Advisors Pvt.Ltd. | Fast Track Finsec Pvt.Ltd. |
| Registrar | Kfin Technologies Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Giriraj Stock Broking Pvt.Ltd. | Nikunj Stock Brokers Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Medicamen Organics IPO is up to ₹9.96 Cr whereas the issue size of the Akiko Global IPO is up to ₹21.95 Cr. The final issue price of Medicamen Organics IPO is ₹34.00 per share and of Akiko Global IPO is ₹77.00 per share.
| Medicamen Organics IPO | Akiko Global IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹32.00 per share | ₹73.00 per share |
| Issue Price (Upper) | ₹34.00 per share | ₹77.00 per share |
| Issue Price (Final) | ₹34.00 per share | ₹77.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 4000 shares | 1600 shares |
| Fresh Issue Size | 29,28,000 shares | 28,51,200 shares |
| Fresh Issue Size (Amount) | up to ₹9.96 Cr | up to ₹21.95 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 29,28,000 shares | 28,51,200 shares |
| Issue Size Total (Amount) | up to ₹9.96 Cr | up to ₹21.95 Cr |
Medicamen Organics IPO opens on Jun 21, 2024, while Akiko Global IPO opens on Jun 25, 2024. The closing date of Medicamen Organics IPO and Akiko Global IPO is Jun 25, 2024, and Jun 27, 2024, respectively.
| Medicamen Organics IPO | Akiko Global IPO | |
|---|---|---|
| Anchor Bid Date | Jun 20, 2024 | Jun 24, 2024 |
| Issue Open | Jun 21, 2024 | Jun 25, 2024 |
| Issue Close | Jun 25, 2024 | Jun 27, 2024 |
| Basis Of Allotment (Tentative) | Jun 26, 2024 | Jul 01, 2024 |
| Initiation of Refunds (Tentative) | Jun 27, 2024 | Jul 01, 2024 |
| Credit of Share (Tentative) | Jun 27, 2024 | Jul 01, 2024 |
| Listing date (Tentative) | Jun 28, 2024 | Jul 02, 2024 |
| Anchor Lockin End date 1 | Jul 26, 2024 | Jul 31, 2024 |
| Anchor Lockin End date 2 | Sep 24, 2024 | Sep 29, 2024 |
Medicamen Organics IPO P/E ratio is 30.53, as compared to Akiko Global IPO P/E ratio of 13.2.
| Medicamen Organics IPO | Akiko Global IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Medicamen Organics Limited Financial Information (Restated)Medicamen Organics Limited's revenue increased by 10.13% and profit after tax (PAT) rose by 151% between the financial year ending with March 31, 2024 and March 31, 2023.
| Akiko Global Services Limited Financial Information (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 81.21 | 92.77 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 66.91 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 30.53 | 13.2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹39.78 Cr. | ₹82.93 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 19.90% | 32.44% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 14.50% | 29.23% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.83 | 0.09 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹1.11 | ₹5.83 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 15.83 | 22.91% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Medicamen Organics IPO Retail Individual Investors (RII) are offered 10,28,000 shares while in Akiko Global IPO retail investors are offered 10,28,000 shares. Qualified Institutional Buyers (QIB) are offered 5,84,000 shares in Medicamen Organics IPO and 5,69,600 shares in Akiko Global IPO.
| Medicamen Organics IPO | Akiko Global IPO | |
|---|---|---|
| Anchor Investor Reserveration | 8,76,000 shares | 8,54,400 shares |
| Market Maker Reserveration | 1,72,000 shares | 1,50,400 shares |
| QIB | 5,84,000 shares | 5,69,600 shares |
| NII | 4,40,000 shares | 4,28,800 shares |
| RII | 10,28,000 shares | 9,98,400 shares |
| Employee | ||
| Others | ||
| Total | 29,28,000 shares | 28,51,200 shares |
Medicamen Organics IPO subscribed 993.56x in total, whereas Akiko Global IPO subscribed 34.96x.
| Medicamen Organics IPO | Akiko Global IPO | |
|---|---|---|
| QIB (times) | 173.03x | 10.21x |
| NII (times) | 1,343.83x | 48.05x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1,309.77x | 45.57x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 993.56x | 34.96x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
